This inventor holds 4 USPTO granted patents. Top assignees: Merck + Co., Inc., Pfizer Corporation. Active years: 2002-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2008
Title: The Innovative Journey of Yingjie Lai: A Pioneer in Pharmaceutical Patents
Introduction: Yingjie Lai, an accomplished inventor based in Edison, NJ, has made significant contributions to the field of pharmaceutical innovations. With a portfolio of four patents, his work focuses on vital health-related issues such as obesity, diabetes, and Alzheimer's disease.
Latest Patents: Yingjie Lai’s latest innovations reflect his commitment to addressing pressing medical challenges. One of his notable patents, titled "Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists," introduces novel N-acylated spiropiperidine derivatives that act as selective agonists of the human melanocortin-4 receptor (MC-4R). These compounds hold promise for treating various disorders, including obesity, diabetes, and sexual dysfunction. Another significant creation is a method for inhibiting amyloid protein aggregation and imaging amyloid deposits, aimed at advancing the treatment of Alzheimer's disease. This patent provides a method of employing compounds of Formula (I) to inhibit the aggregation of amyloid proteins and imaging techniques to identify amyloid deposits.
Career Highlights: Throughout his career, Yingjie Lai has lent his expertise to leading pharmaceutical giants. He has worked with renowned companies such as Merck & Company, Inc. and Pfizer Corporation, where he has played a pivotal role in the development of groundbreaking therapeutics. His work in these organizations has not only advanced scientific understanding but also contributed to the commercialization of innovative medical solutions.
Collaborations: Collaboration is key in the world of innovation, and Yingjie Lai has teamed up with notable colleagues, including Ravi P. Nargund and Iyassu K. Sebhat. Their combined expertise has led to advancements in their respective fields, demonstrating the power of teamwork in driving innovation.
Conclusion: Yingjie Lai's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents, focused on crucial health issues, showcase his dedication to improving human health through innovative solutions. As he continues to push the boundaries of science, Yingjie Lai stands as a testament to the impact that inventors can have on society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile